1. Sung, H, Ferlay, J, Siegel, RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-249. doi:10.3322/caac.21660
Google Scholar | Crossref | Medline2. Song, Y, Li, L, Ou, Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509:91-95. doi:10.1038/nature13176
Google Scholar | Crossref | Medline | ISI3. Rustgi, AK, El-Serag, HB. Esophageal carcinoma. N Engl J Med. 2014;371:2499-2509. doi:10.1056/NEJMra1314530
Google Scholar | Crossref | Medline | ISI4. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424. doi:10.3322/caac.21492
Google Scholar | Crossref | Medline5. Huang, FL, Yu, SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41:210-215. doi:10.1016/j.asjsur.2016.10.005
Google Scholar | Crossref | Medline6. Zhao, L, Li, YC, Wu, JP, et al. Increased risk of esophageal squamous cell carcinoma associated with frequent and long-term consumption of salted meat and salted fat. J Int Med Res. 2019;47:3841-3849. doi:10.1177/0300060519859729
Google Scholar | SAGE Journals | ISI7. Ohnuma, H, Sato, Y, Hayasaka, N, et al. Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: a phase II study. Cancer Sci. 2018;109:3554-3563. doi:10.1111/cas.13772
Google Scholar | Crossref | Medline8. Kato, K, Cho, BC, Takahashi, M, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20:1506-1517. doi:10.1016/S1470-2045(19)30626-6
Google Scholar | Crossref | Medline9. Elliott, JA, Docherty, NG, Eckhardt, HG, et al. Weight loss, satiety, and the postprandial gut hormone response after Esophagectomy: a prospective study. Ann Surg. 2017;266:82-90. doi:10.1097/SLA.0000000000001918
Google Scholar | Crossref | Medline10. Wang, WJ, Zhang, T. Integration of traditional Chinese medicine and Western medicine in the era of precision medicine. J Integr Med. 2017;15:1-7. doi:10.1016/S2095-4964(17)60314-5
Google Scholar | Crossref | Medline11. Li, L, Yao, H, Wang, J, Li, Y, Wang, Q. The role of Chinese medicine in health maintenance and disease prevention: application of constitution theory. Am J Chin Med. 2019; 47:495-506. doi:10.1142/S0192415X19500253
Google Scholar | Crossref | Medline12. Zhou, W, Wu, J, Zhang, J, et al. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology. Sci Rep. 2020;10:12745. doi:10.1038/s41598-020-69708-2
Google Scholar | Crossref13. Shi, Q, Diao, Y, Jin, F, Ding, Z. Anti-metastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelial-mesenchymal transition and angiogenesis. Mol Med Rep. 2018;18:131-138. doi:10.3892/mmr.2018.8976
Google Scholar | Crossref | Medline14. Fan, W, Sun, L, Zhou, JQ, et al. Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway. Chin J Nat Med. 2015;13:428-437. doi:10.1016/S1875-5364(15)30036-4
Google Scholar | Crossref | Medline15. Cui, Z, Liu, W, Zhou, Y, et al. [Curative effect of Jiedu Shengji recipe in preventing and treating acute radiation esophagitis in radiotherapy induced esophageal carcinoma patients]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016;36:810-813.
Google Scholar | Medline16. Shi, H, Shi, D, Wu, Y, Shen, Q, Li, J. Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function. Cancer Lett. 2016;380:184-190. doi:10.1016/j.canlet.2016.06.015
Google Scholar | Crossref | Medline17. Rauf, A, Abu-Izneid, T, Olatunde, A, et al. COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies. Int J Environ Res Public Health. 2020;17:E8155. doi:10.3390/ijerph17218155
Google Scholar | Crossref18. Song, Q, Yang, W, Meng, Z, Wang, J. Protocol for a systematic review and meta-analysis of Kang-ai injection for patients with oesophageal cancer. Medicine. 2020;99:e22148. doi:10.1097/MD.0000000000022148
Google Scholar | Crossref19. Zhang, D, Wu, J, Wang, H, et al. Systematic review and network meta-analysis comparing Chinese herbal injections with chemotherapy for treating patients with esophageal cancer. J Int Med Res. 2020;48:300060519898336. doi:10.1177/0300060519898336
Google Scholar | SAGE Journals20. Liu, Z, Dong, Y, Zhu, M, Mu, Y, Chen, L. Xiaoaiping injection as adjunct therapy for patients with advanced esophageal carcinoma: a protocol for a systematic review and meta-analysis. Medicine. 2020;99:e20984. doi:10.1097/MD.0000000000020984
Google Scholar | Crossref21. Ying, J, Zhang, M, Qiu, X, Lu, Y. The potential of herb medicines in the treatment of esophageal cancer. Biomed Pharmacother. 2018;103:381-390. doi:10.1016/j.biopha.2018.04.088
Google Scholar | Crossref | Medline22. Cai, YM, Zhu, H, Niu, JX, et al. Identification of herb pairs in esophageal cancer. Complement Med Res. 2017;24:40-45. doi:10.1159/000454699
Google Scholar | Crossref | Medline23. Kong, L, Wu, Z, Zhao, Y, et al. Qigesan reduces the motility of esophageal cancer cells via inhibiting Gas6/Axl and NF-κB expression. Biosci Rep. 2019;39:BSR20190850. doi:10.1042/BSR20190850
Google Scholar | Crossref24. Yang, X, Li, Y, Qian, H. Study on the selection of the targets of esophageal carcinoma and interventions of Ginsenosides based on network pharmacology and bioinformatics. Evid Based Complement Alternat Med. 2020;2020:4821056. doi:10.1155/2020/4821056
Google Scholar | Crossref25. Wang, TH, Wan, JY, Gong, X, Li, HZ, Cheng, Y. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Oncol Rep. 2012;28:1681-1686. doi:10.3892/or.2012.1999
Google Scholar | Crossref | Medline26. Jia, YS, Hu, XQ, Li, JA, Andras, S, Hegyi, G, Han, BS. Tonglian decoction () arrests the cell cycle in S-phase by targeting the nuclear factor-kappa B signal pathway in esophageal carcinoma Eca109 cells. Chin J Integr Med. 2016;22:384-389. doi:10.1007/s11655-016-2096-3
Google Scholar | Crossref | Medline27. Liang, X, Wang, Q, Jiang, Z, et al. Clinical research linking Traditional Chinese medicine constitution types with diseases: a literature review of 1639 observational studies. J Tradit Chin Med. 2020;40:690-702. doi:10.19852/j.cnki.jtcm.2020.04.019
Google Scholar | Crossref | Medline28. Liu, Y, Pan, T, Zou, W, et al. Relationship between traditional Chinese medicine constitutional types with chemotherapy-induced nausea and vomiting in patients with breast cancer: an observational study. BMC Complement Altern Med. 2016;16:451. doi:10.1186/s12906-016-1415-3
Google Scholar | Crossref | Medline29. Yin, SG, Wang, HH, Wu, YS, Chen, YL. Study of Liujunzi Tang extract on inhibiting human esophageal carcinom Eca109 cells growth. Chin J Exp Tradi Med Form. 2015;21:163-166.
Google Scholar30. Si, FC . Effects of Qigesan, Shashenmaidongtang, Tongyoutang and Buqiyunpitang on hEGF-stimulated proliferation of human esophageal carcinoma EC9706 cells. World Chin J Dig. 2010;18:2956-2965.
Google Scholar | Crossref31. Du, HX, Huang, ZX, Yao, CC. Effect of Xiaochaihu decoction on the proliferation and apoptosis of human Esophageal cancer cell line Eca-109. Guangming J Chin Med. 2014;29:51-54.
Google Scholar32. Wu, CY, Song, Z, Li, J. Experience of Qizhu Yuling decoction in treating esophageal cancer. J Tradit Chin Med. 2016;57:1879-1881.
Google Scholar33. Institute of Chinese Medicine Guang’anmen Hospital . Curative effect of Liuwei Dihuang pill on 30 cases of esophageal epithelial cell hyperplasia. J Tradit Chin Med. 1977;25-26.
Google Scholar34. Wu, YS, Yang, LH, Guo, B, et al. Synergistic inhibition effect of qige powder and cisplatin on esophageal EC9706 cell growth mediated by miR-21. Chin Arch Tradit Chin Med. 2017;35:3098-3101.
Google Scholar35. Bureau, THH . Prescriptions of the Bureau of Taiping People’s Welfare. People’s Medical Publishing House; 2007.
Google Scholar36. Lin, DR . Secret Recipes of Treating Wounds and Bone-Setting Taught by Celestials. People’s Medical Publishing House; 1957.
Google Scholar37. Zhang, ZJ . Treatise on Cold-Attack. People’s Medical Publishing House; 2005.
Google Scholar38. Li, DY . Theory of Spleen and Stomach. People’s Medical Publishing House; 2005.
Google Scholar39. Wu, JT . Febrile Disease Differentiation. People’s Medical Publishing House; 2005.
Google Scholar40. Cheng, GP . Medicine Comprehended. People’s Medical Publishing House; 2006.
Google Scholar41. Wang, QR . Medical Forest Correction. People’s Medical Publishing House; 2005.
Google Scholar42. Qian, Y . Key to the Therapeutics of Children's Diseases. People’s Medical Publishing House; 2006.
Google Scholar43. Li, DY . The Theory of Internal and External Injury Differentiation. People’s Medical Publishing House; 2007.
Google Scholar44. Ge, H . Elbow Backup Emergency. China Traditional Chinese Medicine Publishing House; 2018.
Google Scholar45. Zhang, XC . Integrating Chinese and Western Medicine. People’s Medical Publishing House; 2006.
Google Scholar46. Chen, Y . Three-Cause-One-Disease-Syndrome Theory. People’s Medical Publishing House; 2007.
Google Scholar47. Taylor, PR, Abnet, CC, Dawsey, SM. Squamous dysplasia—the precursor lesion for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:540-552. doi:10.1158/1055-9965.EPI-12-1347
Google Scholar | Crossref | Medline | ISI48. Zhang, GH, Su, M, Tian, DP, et al. Analysis of basement membrane structure and inflammation during the development of esophageal squamous cell carcinoma in the Chinese Chaoshan high risk region. Cancer Investig. 2008;26:296-305. doi:10.1080/07357900701683901
Google Scholar | Crossref | Medline49. Lin, J, Zeng, R, Cao, W, Luo, R, Chen, J, Lin, Y. Hot beverage and food intake and esophageal cancer in southern China. Asian Pac J Cancer Prev. 2011;12:2189-2192.
Google Scholar | Medline50. Hou, J, Yan, FR, Li, SS, Li, ZY, Chen, ZF. Clinical study of compound Cangdou pills on precancerous lesions of esophageal cancer. Chin J Integr Tradit West Med. 1992;10:604-606. +581.
Google Scholar51. Zhang, JS, Lin, PZ, Rong, ZP, et al. Blocking treatment of precancerous lesions of esophagus with anti-cancer B tablets. J Tradit Chin Med. 1990;10:23-25.
Google Scholar52. Liu, YL . Clinical analysis of 60 cases of esophageal mucosal atypical hyperplasia treated with Xinkaikujiang method. J Hebei Trad Chin Med Pharmacol. 2013;28:18-19.
Google Scholar53. Zhang, DX, Wang, X. 29 cases of esophageal epithelial atypical hyperplasia treated by Qingre Huoxue mixture. Chin J Integr Tradit West Med Dig. 2011;19:55-56.
Google Scholar54. Wang, P, Wang, Y. Clinical observation on 52 cases of esophageal epithelial hyperplasia treated with modified Liuwei Dihuang decoction. J Sichuan Trad Chin Med. 2005; 23:55.
Google Scholar55. Zhang, YS, Gao, J, Shi, HJ, Shi, DX, Li, J. Effect of modified qigesan on the recurrence and metastasis rate and quality of life among patients after radical resection of Esophageal carcinoma. Chin Gen Pract. 2018;21:1239-1243.
Google Scholar56. Baba, Y, Baba, H, Yamamoto, S, et al. Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan. Dis Esophagus. 2017;30:1-7. doi:10.1111/dote.12482
Google Scholar | Crossref57. Derogar, M, Orsini, N, Sadr-Azodi, O, Lagergren, P. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol. 2012;30:1615-1619. doi:10.1200/JCO.2011.40.3568
Google Scholar |